IVM Survey Among Reproductive Medicine Specialists

Sponsor
Universitair Ziekenhuis Brussel (Other)
Overall Status
Completed
CT.gov ID
NCT04488211
Collaborator
CooperSurgical Inc. (Industry)
200
1
5.1
39.5

Study Details

Study Description

Brief Summary

Although IVM as a laboratory technology in reproductive medicine has existed for many decades, there is a lack of well-designed studies comparing the efficiency and the patient satisfaction related to IVM as compared to standard ovarian stimulation for IVF. In view of this, and in order to identify unmet needs of fertility specialists with regard to the application of IVM, the investigator developed the idea of a worldwide web-based survey analysis of fertility specialists' insights and experiences regarding IVM.

Condition or Disease Intervention/Treatment Phase
  • Other: Survey

Detailed Description

The IVM survey will be structured as a series of open questions and multiple-choice questions. In most of the questions, a single answer will be required by participants. A small number of questions will allow multiple answers. The survey will be web-based. Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic. Clinics will be identified based on whether they have worked with IVM previously but stopped, and clinics with appropriate size to offer IVM competence. When no response is obtained from selected fertility specialists, e-mails will be sent to affiliated colleagues working at the same fertility clinic. When analyzing the survey results, care will be taken to analyse the responses per fertility clinic, as responses from different fertility specialists working in the same fertility clinic should be avoided. Results will be analysed using a method that assigns equal weight per clinic and a method that weights clinic responses based on treatment volume (number of IVF cycles).

Study Design

Study Type:
Observational
Actual Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Survey of Fertility Specialists' Knowledge of, Experience With, and Attitudes Toward the Use of in Vitro Maturation of Oocytes in Reproductive Medicine
Actual Study Start Date :
Jul 30, 2020
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Prospective survey respondents

Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic.

Other: Survey
The IVM survey will be structured as a series of open questions and multiple-choice questions.

Outcome Measures

Primary Outcome Measures

  1. Name of the measurement: Application of in vitro maturation (IVM) of oocytes as a laboratory tool [1 month]

    Measurement tool: questionnaire; unit of measure: % of respondents who use oocyte in vitro maturation in the laboratory;

  2. Name of the measurement: Appreciation of IVM as a laboratory technique [1 month]

    Measurement tool: questionnaire; unit of measure: % of respondents who believe there is a role for IVM in the ART (assisted reproductive technology ) clinic

Secondary Outcome Measures

  1. Name of the measurement: Annual number of egg retrievals for IVM [1 month]

    Measurement tool: questionnaire; unit of measure: number

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • IVF clinics that have worked with IVM previously but stopped

  • clinics with appropriate size to offer IVM

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universitair Ziekenhuis Brussel Brussel Belgium

Sponsors and Collaborators

  • Universitair Ziekenhuis Brussel
  • CooperSurgical Inc.

Investigators

  • Principal Investigator: Michel De Vos, Universitair Ziekenhuis Brussel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitair Ziekenhuis Brussel
ClinicalTrials.gov Identifier:
NCT04488211
Other Study ID Numbers:
  • IVM Survey V2 04062020
First Posted:
Jul 27, 2020
Last Update Posted:
May 4, 2021
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 4, 2021